Exelixis | Capital Y Las Reservas



Equity Capital And Reserves Cambio Fecha
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Bayer EUR 32.58B 537M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Cytokinetics USD -266413000 131.04M 2025-03
Eisai JPY 841.42B 31.94B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.13B 113.18M 2025-04
Genmab DKK 5.3B 31.4B 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Sanofi 77.86B 4.86B 2024-12
Takeda JPY 6.94T 483.19B 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Xencor USD 639.87M 37.74M 2025-03



Exelixis Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.